Xiao Feng Chen
Director/Board Member at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Xiao Feng Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Director/Board Member | 2011-08-18 | - |
Career history of Xiao Feng Chen
Former positions of Xiao Feng Chen
| Companies | Position | Start | End |
|---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Director/Board Member | 2011-08-18 | - |
| SINO BIOPHARMACEUTICAL LIMITED | Comptroller/Controller/Auditor | 2011-08-18 | - |
Statistics
International
| China | 3 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
- Stock Market
- Insiders
- Xiao Feng Chen
- Experience
